Works by Wen, Binhong


Results: 8
    1
    2
    3

    Higher versus standard starting dose of insulin glargine 100 U/mL in overweight or obese Chinese patients with type 2 diabetes: Results of a multicentre, open‐label, randomized controlled trial (BEYOND VII).

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 5, p. 838, doi. 10.1111/dom.13967
    By:
    • Ji, Linong;
    • Wan, Hailong;
    • Wen, Binhong;
    • Wang, Xueying;
    • Wang, Junfen;
    • Bian, Rongwen;
    • Pang, Wuyan;
    • Tian, Jian;
    • Wang, Yan;
    • Bian, Fang;
    • Gao, Zhengnan;
    • Condoleon, Alex;
    • Feng, Wei;
    • Zhang, Xia;
    • Cui, Nan
    Publication type:
    Article
    4
    5
    6
    7
    8